Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 2 | Breast Cancer Research

Figure 2

From: Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma

Figure 2

Relapse-free survival curves. (a) Patients with strong NAT1 overexpression (1), patients with moderate NAT1 overexpression (2) and patients with normal NAT1 expression (3). (b) Patients with FMO5 overexpression (1) and patients with normal FMO5 expression (2). (c) Patients with strong CYP2B6 overexpression (1), patients with moderate CYP2B6 overexpression (2) and patients with normal CYP2B6 expression (3). NS, not significant.

Back to article page